Seven Novel Single Nucleotide Polymorphisms in the Human SLC22A1 Gene Encoding Organic Cation Transporter 1 (OCT1)-Reference-Cited by-同舟云学术

Seven Novel Single Nucleotide Polymorphisms in the Human SLC22A1 Gene Encoding Organic Cation Transporter 1 (OCT1)

Published:2004 Issue:4 Volume:19 Page:308-312
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Itoda Masaya,Saito Yoshiro,Maekawa Keiko,Hichiya Hiroyuki,Komamura Kazuo,Kamakura Shiro,Kitakaze Masafumi,Tomoike Hitonobu,Ueno Kazuyuki,Ozawa Shogo,Sawada Jun-ichi

Publisher

Japanese Society for the Study of Xenobiotics

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference14 articles.

1. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3);Jonker;J. Pharmacol. Exp. Ther.,2004

2. Structure of renal organic anion and cation transporters;Burckhardt;Am. J. Physiol. Renal. Physiol.,2000

3. Cloning and functional expression of a human liver organic cation transporter;Zhang;Mol. Pharmacol.,1997

4. Cloning and characterization of two human polyspecific organic cation transporters;Gorboulev;DNA Cell. Biol.,1997

5. Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene;Jonker;Mol. Cell. Biol.,2001

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Single Nucleotide Polymorphism in OCT1 and OCT3 Genes with the Efficacy of Metformin Response in North Indian Type 2 Diabetes Mellitus Patients.;2023-08-09

2. Organic Cation Transporters in Health and Disease;Pharmacological Reviews;2019-12-18

Role of OCT1 in hepatocellular carcinoma

;OncoTargets and Therapy;2019-07

4. Genetic variations in influx transporter gene SLC22A1 are associated with clinical responses to imatinib mesylate among Malaysian chronic myeloid leukaemia patients;Journal of Genetics;2018-08-17

5. Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan;International Journal of Hematology;2018-04-30